Publication

Paclitaxel prodrugs, method for preparation as well as their use in selective chemotherapy

de Bont, H. BA., Leenders, R. GG., Scheeren, J. W., Haisma, H. J. & de Vos, D., 2-Jun-1998, IPC No. C07H 13/ 12 A I, Patent No. US5760072, Priority date 29-Dec-1995, Priority No. EP19950203671

Research output: PatentProfessional

APA

de Bont, H. BA., Leenders, R. GG., Scheeren, J. W., Haisma, H. J., & de Vos, D. (1998). IPC No. C07H 13/ 12 A I. Paclitaxel prodrugs, method for preparation as well as their use in selective chemotherapy. (Patent No. US5760072).

Author

de Bont, Hendricus BA (Inventor) ; Leenders, Ruben GG (Inventor) ; Scheeren, Johan W (Inventor) ; Haisma, Hidde J (Inventor) ; de Vos, Dick (Inventor). / Paclitaxel prodrugs, method for preparation as well as their use in selective chemotherapy. IPC No.: C07H 13/ 12 A I. Patent No.: US5760072.

Harvard

de Bont, HBA, Leenders, RGG, Scheeren, JW, Haisma, HJ & de Vos, D 1998, Paclitaxel prodrugs, method for preparation as well as their use in selective chemotherapy, Patent No. US5760072, IPC No. C07H 13/ 12 A I.

Standard

Paclitaxel prodrugs, method for preparation as well as their use in selective chemotherapy. / de Bont, Hendricus BA (Inventor); Leenders, Ruben GG (Inventor); Scheeren, Johan W (Inventor); Haisma, Hidde J (Inventor); de Vos, Dick (Inventor).

IPC No.: C07H 13/ 12 A I. Patent No.: US5760072.

Research output: PatentProfessional

Vancouver

de Bont HBA, Leenders RGG, Scheeren JW, Haisma HJ, de Vos D, inventors. Paclitaxel prodrugs, method for preparation as well as their use in selective chemotherapy. C07H 13/ 12 A I. 1998 Jun 2.


BibTeX

@misc{103cdaa4b7fe408db0a954293863ff0b,
title = "Paclitaxel prodrugs, method for preparation as well as their use in selective chemotherapy",
abstract = "A paclitaxel prodrug has a paclitaxel portion coupled to a cleavable N-(aliphatic or aromatic)-O-glycosyl carbamate spacer group, and can be administered orally, topically or by injection to provide an anti-tumor effect, the prodrug being activated by a hydrolizing enzyme, an endogeneous enzyme or an exogeneous enzyme.",
author = "{de Bont}, {Hendricus BA} and Leenders, {Ruben GG} and Scheeren, {Johan W} and Haisma, {Hidde J} and {de Vos}, Dick",
note = "US Patent 5,760,072; US5760072; C07H 13/ 12 A I",
year = "1998",
month = "6",
day = "2",
language = "English",
type = "Patent",

}

RIS

TY - PAT

T1 - Paclitaxel prodrugs, method for preparation as well as their use in selective chemotherapy

AU - de Bont, Hendricus BA

AU - Leenders, Ruben GG

AU - Scheeren, Johan W

AU - Haisma, Hidde J

AU - de Vos, Dick

N1 - US Patent 5,760,072

PY - 1998/6/2

Y1 - 1998/6/2

N2 - A paclitaxel prodrug has a paclitaxel portion coupled to a cleavable N-(aliphatic or aromatic)-O-glycosyl carbamate spacer group, and can be administered orally, topically or by injection to provide an anti-tumor effect, the prodrug being activated by a hydrolizing enzyme, an endogeneous enzyme or an exogeneous enzyme.

AB - A paclitaxel prodrug has a paclitaxel portion coupled to a cleavable N-(aliphatic or aromatic)-O-glycosyl carbamate spacer group, and can be administered orally, topically or by injection to provide an anti-tumor effect, the prodrug being activated by a hydrolizing enzyme, an endogeneous enzyme or an exogeneous enzyme.

M3 - Patent

M1 - US5760072

ER -

ID: 40101713